Women who discontinue bisphosphonates for more than two years have up to a 40% greater risk of hip fracture, a US study presented at EULAR 2018 here in Amsterdam has shown. Taking bisphosphonate therapy for three to four years is known to reduce fracture risk in osteoporotic women, but the question of how long to ...
Fracture rates rise after bisphosphonate holiday
By Ingrid Torjesen
20 Jun 2018